ATE372342T1 - Substituierte aminoisoxazolinderivate und ihre verwendung als antidepressiva - Google Patents

Substituierte aminoisoxazolinderivate und ihre verwendung als antidepressiva

Info

Publication number: ATE372342T1
Authority: AT; Austria
Prior art keywords: aminoisoxazoline; antidepressants; derivatives; substituted; substituted aminoisoxazoline
Prior art date: 2002-04-02

Application number

AT03714897T

Other languages

English (en)

Inventor

Jose Andres-Gil

Manuel Alcazar-Vaca

Margaretha Henrica Mari Bakker

Lucas Olivares Ana De

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-02

Filing date

2003-03-27

Publication date

2007-09-15

2003-03-27 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2007-09-15 Application granted granted Critical

2007-09-15 Publication of ATE372342T1 publication Critical patent/ATE372342T1/de

Links

XPZOKPQZEPSMFC-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazol-3-amine Chemical class NC1=NOCC1 XPZOKPQZEPSMFC-UHFFFAOYSA-N 0.000 title 1
239000000935 antidepressant agent Substances 0.000 title 1
229940005513 antidepressants Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Anesthesiology (AREA)
Child & Adolescent Psychology (AREA)
Addiction (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

AT03714897T 2002-04-02 2003-03-27 Substituierte aminoisoxazolinderivate und ihre verwendung als antidepressiva ATE372342T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02076239		2002-04-02

Publications (1)

Publication Number	Publication Date
ATE372342T1 true ATE372342T1 (de)	2007-09-15

Family

ID=28459528

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03714897T ATE372342T1 (de)	2002-04-02	2003-03-27	Substituierte aminoisoxazolinderivate und ihre verwendung als antidepressiva

Country Status (24)

Country	Link
US (1)	US7265103B2 (de)
EP (1)	EP1492796B1 (de)
JP (1)	JP4580653B2 (de)
KR (1)	KR20040093061A (de)
CN (1)	CN100349897C (de)
AR (1)	AR039207A1 (de)
AT (1)	ATE372342T1 (de)
BR (1)	BR0308309A (de)
CA (1)	CA2480113C (de)
DE (1)	DE60316134T2 (de)
DK (1)	DK1492796T3 (de)
EA (1)	EA008189B1 (de)
ES (1)	ES2292949T3 (de)
HK (1)	HK1080072A1 (de)
HR (1)	HRP20040871A2 (de)
IL (2)	IL164341A0 (de)
MX (1)	MXPA04008626A (de)
NO (1)	NO20044645L (de)
NZ (1)	NZ536109A (de)
PL (1)	PL211708B1 (de)
PT (1)	PT1492796E (de)
TW (1)	TWI286138B (de)
WO (1)	WO2003082878A1 (de)
ZA (1)	ZA200407904B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR040967A1 (es) *	2002-08-12	2005-04-27	Janssen Pharmaceutica Nv	Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
ATE387455T1 (de) *	2002-08-21	2008-03-15	Janssen Pharmaceutica Nv	C6- und c9-substituierte chromeno(4,3- c)isoxazoline und ihre verwendung als anti- depressiva
JP2008521771A (ja)	2004-11-26	2008-06-26	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	改良された抗精神病活性および抗不安症活性を有するイソキサゾリン−インドール誘導体
CA2691704A1 (en) *	2007-07-03	2009-01-08	F. Hoffmann-La Roche Ag	4-imidazolines and their use as antidepressants
EP2406243B1 (de)	2009-03-10	2014-05-07	Takeda Pharmaceutical Company Limited	Benzofuranderivate
US20130062732A1 (en)	2011-09-08	2013-03-14	International Business Machines Corporation	Interconnect structures with functional components and methods for fabrication
CN105801510A (zh) *	2016-04-08	2016-07-27	李勇	一种治疗抑郁症的药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2055011T3 (es)	1988-09-19	1994-08-16	Akzo Nv	Un procedimiento para la preparacion de derivados de tetrahidronaftaleno e indano.
AU710059B2 (en) *	1996-01-05	1999-09-09	Aventis Pharmaceuticals Inc.	4,5-dihydronaphth(1,2-C)isoxazoles and derivatives thereof having CNS activity
US6187774B1 (en) *	1996-03-04	2001-02-13	Yoshitomi Pharmaceutical Industries, Ltd.	Fused heterocyclic compounds and pharmaceutical applications thereof
MXPA03007432A (es) *	2001-02-21	2003-11-18	Janssen Pharmaceutica Nv	Derivados de isoxazolinas y su uso como antidepresivos.
AR040967A1 (es) *	2002-08-12	2005-04-27	Janssen Pharmaceutica Nv	Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
ATE387455T1 (de) *	2002-08-21	2008-03-15	Janssen Pharmaceutica Nv	C6- und c9-substituierte chromeno(4,3- c)isoxazoline und ihre verwendung als anti- depressiva

2003
- 2003-03-27 NZ NZ536109A patent/NZ536109A/en unknown
- 2003-03-27 AT AT03714897T patent/ATE372342T1/de not_active IP Right Cessation
- 2003-03-27 EP EP03714897A patent/EP1492796B1/de not_active Expired - Lifetime
- 2003-03-27 MX MXPA04008626A patent/MXPA04008626A/es active IP Right Grant
- 2003-03-27 IL IL16434103A patent/IL164341A0/xx unknown
- 2003-03-27 HR HR20040871A patent/HRP20040871A2/hr not_active Application Discontinuation
- 2003-03-27 CN CNB038074192A patent/CN100349897C/zh not_active Expired - Fee Related
- 2003-03-27 EA EA200401297A patent/EA008189B1/ru not_active IP Right Cessation
- 2003-03-27 US US10/510,220 patent/US7265103B2/en not_active Expired - Lifetime
- 2003-03-27 WO PCT/EP2003/003245 patent/WO2003082878A1/en not_active Ceased
- 2003-03-27 PT PT03714897T patent/PT1492796E/pt unknown
- 2003-03-27 DK DK03714897T patent/DK1492796T3/da active
- 2003-03-27 BR BR0308309-8A patent/BR0308309A/pt not_active IP Right Cessation
- 2003-03-27 KR KR10-2004-7012757A patent/KR20040093061A/ko not_active Ceased
- 2003-03-27 JP JP2003580343A patent/JP4580653B2/ja not_active Expired - Fee Related
- 2003-03-27 ES ES03714897T patent/ES2292949T3/es not_active Expired - Lifetime
- 2003-03-27 CA CA2480113A patent/CA2480113C/en not_active Expired - Fee Related
- 2003-03-27 PL PL371630A patent/PL211708B1/pl unknown
- 2003-03-27 HK HK05112213.1A patent/HK1080072A1/zh unknown
- 2003-03-27 DE DE60316134T patent/DE60316134T2/de not_active Expired - Lifetime
- 2003-04-01 AR ARP030101126A patent/AR039207A1/es unknown
- 2003-04-01 TW TW092107328A patent/TWI286138B/zh not_active IP Right Cessation
2004
- 2004-09-28 IL IL164341A patent/IL164341A/en not_active IP Right Cessation
- 2004-09-30 ZA ZA200407904A patent/ZA200407904B/xx unknown
- 2004-10-27 NO NO20044645A patent/NO20044645L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2480113A1 (en)	2003-10-09
ZA200407904B (en)	2005-10-20
DK1492796T3 (da)	2007-12-03
CN1642960A (zh)	2005-07-20
HK1080072A1 (zh)	2006-04-21
IL164341A0 (en)	2005-12-18
TWI286138B (en)	2007-09-01
EA200401297A1 (ru)	2005-02-24
PT1492796E (pt)	2007-11-16
EP1492796B1 (de)	2007-09-05
JP2005522469A (ja)	2005-07-28
NO20044645L (no)	2004-10-27
ES2292949T3 (es)	2008-03-16
PL211708B1 (pl)	2012-06-29
KR20040093061A (ko)	2004-11-04
TW200406414A (en)	2004-05-01
DE60316134T2 (de)	2008-05-29
PL371630A1 (en)	2005-06-27
AR039207A1 (es)	2005-02-09
CN100349897C (zh)	2007-11-21
CA2480113C (en)	2012-04-24
JP4580653B2 (ja)	2010-11-17
BR0308309A (pt)	2004-12-28
US7265103B2 (en)	2007-09-04
US20050222125A1 (en)	2005-10-06
WO2003082878A1 (en)	2003-10-09
EP1492796A1 (de)	2005-01-05
NZ536109A (en)	2006-06-30
DE60316134D1 (de)	2007-10-18
AU2003219111A1 (en)	2003-10-13
HRP20040871A2 (en)	2005-04-30
MXPA04008626A (es)	2004-12-06
EA008189B1 (ru)	2007-04-27
IL164341A (en)	2009-06-15

Legal Events

Date

Code

Title

Description

2008-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1492796

Country of ref document: EP

2010-12-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE60314600D1 (de)	2007-08-09	O-cyclopropyl-carboxanilide und ihre verwendung als fungizide
DE60309874D1 (de)	2007-01-04	Malonsäuerenitril-verbindungen und ihre verwendung als pestizide
DE60317093D1 (de)	2007-12-06	Chinolin-; isochinolin- und chinazolinoxyalkylamide und ihre verwendung als fungizide
ATE371658T1 (de)	2007-09-15	Purinderivate und ihre verwendung als liganden des cannabinoid rezeptors
ATE424202T1 (de)	2009-03-15	Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung
DE60036803D1 (de)	2007-11-29	Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel
DE50207849D1 (de)	2006-09-28	Substituierte 2-oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre verwendung
DE60208661D1 (de)	2006-04-06	Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren
DE60321043D1 (de)	2008-06-26	Biphenylderivate und deren verwendung als fungizide
DE602004028934D1 (de)	2010-10-14	Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung
DE60321958D1 (de)	2008-08-14	Indazolderivate und ihre verwendung als crf antagonisten
ATE440093T1 (de)	2009-09-15	1-alkinyl-2-aryloxyalkylamide und ihre verwendung als fungizide
DE602004010426D1 (de)	2008-01-10	Mikrobizide zusammensetzungen und ihre verwendung
ATE432701T1 (de)	2009-06-15	Indol-6-sulfonamid-derivate, ihre herstellung und ihre verwendung als 5-ht-6 modulatoren
ATE329906T1 (de)	2006-07-15	Substituierte 2-anilino-benzimidazole und ihre verwendung als nhe-inhibitoren
DE60318733D1 (de)	2008-03-06	Substituierte benzoxazinones und ihre verwendung
DE50313157D1 (de)	2010-11-18	Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
ATE362469T1 (de)	2007-06-15	2,7-disubstituierteindole und ihre verwendung als 5-ht6 modulatoren
DE602004021384D1 (de)	2009-07-16	Indol-5 -sulfonamid-derivate, ihre herstellung und verwendung als 5-ht-6 modulatoren
DE60311598D1 (de)	2007-03-22	Naphthyridin-derivate und ihre verwendung als fungizide
ATE427748T1 (de)	2009-04-15	Pyridin-derivate und ihre verwendung als urotensin ii antagonisten
DE60230162D1 (de)	2009-01-15	Polymerisate und ihre verwendung
ATE396994T1 (de)	2008-06-15	3-phenylpyridoindolderivate, ihre herstellung und verwendung
DE60322926D1 (de)	2008-09-25	Photopolymerisierbare zusammensetzung und verwendung davon
DE60324586D1 (de)	2008-12-18	Substituierte pyridyloxyalkylamide und ihre verwendung als fungizide